Gilberto Schwartsmann

10.1k total citations
244 papers, 6.2k citations indexed

About

Gilberto Schwartsmann is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Gilberto Schwartsmann has authored 244 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 89 papers in Oncology and 46 papers in Cellular and Molecular Neuroscience. Recurrent topics in Gilberto Schwartsmann's work include Neuropeptides and Animal Physiology (40 papers), Cancer therapeutics and mechanisms (26 papers) and Cancer Treatment and Pharmacology (18 papers). Gilberto Schwartsmann is often cited by papers focused on Neuropeptides and Animal Physiology (40 papers), Cancer therapeutics and mechanisms (26 papers) and Cancer Treatment and Pharmacology (18 papers). Gilberto Schwartsmann collaborates with scholars based in Brazil, United States and Netherlands. Gilberto Schwartsmann's co-authors include Rafael Roesler, Adriana Brondani da Rocha, Dennis R.A. Mans, Caroline Brunetto de Farias, Algemir Lunardi Brunetto, Ana Lúcia Abujamra, João Antônio Pêgas Henriques, Daniel C. Damin, Ivana Grivicich and Roberto G. S. Berlinck and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Gilberto Schwartsmann

238 papers receiving 6.0k citations

Peers

Countries citing papers authored by Gilberto Schwartsmann

Since Specialization

Citations

This map shows the geographic impact of Gilberto Schwartsmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilberto Schwartsmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilberto Schwartsmann more than expected).

Fields of papers citing papers by Gilberto Schwartsmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilberto Schwartsmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilberto Schwartsmann. The network helps show where Gilberto Schwartsmann may publish in the future.

Co-authorship network of co-authors of Gilberto Schwartsmann

This figure shows the co-authorship network connecting the top 25 collaborators of Gilberto Schwartsmann. A scholar is included among the top collaborators of Gilberto Schwartsmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilberto Schwartsmann. Gilberto Schwartsmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Does metformin reduce the risk of cancer in obesity and diabetes? A systematic review and meta‐analysis 2024 ·Diabetes Obesity and Metabolism ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Gilberto Schwartsmann, Gilberto Lopes, John R. Petrie, Verônica Colpani, Fernando Gerchman	8
2	Obesity, diabetes, and cancer: epidemiology, pathophysiology, and potential interventions 2023 ·Archives of Endocrinology and Metabolism ·(unknown), (unknown), Gilberto Schwartsmann, Fernando Gerchman	18
3	Isolation of caryatin as an Antiplasmodial component of Symphyopappus casarettoi (Asteraceae) 2020 ·Arca - Repositório Institucional da Fiocruz ·Carlos Leomar Zani, Anthony R. Carroll, Tânia Maria de Almeida Alves, (unknown), Gilberto Schwartsmann, Antoniana U. Krettli, Isabela Penna Cerávolo	0
4	De-mystifying the Epigenetic Free for All: Pharmacophore Modeling for Epigenetic Cancer Therapy 2011 ·Pharmaceutica Analytica Acta ·(unknown), Algemir Lunardi Brunetto, Gilberto Schwartsmann, Rafael Roesler, Ana Lúcia Abujamra	3
5	Mangifera indica L. extract (Vimang) improves the aversive memory in spinocerebellar ataxia type 2 transgenic mice 2011 ·Journal of Pharmacy & Pharmacognosy Research ·Natasha Maurmann, Caroline Brunetto de Farias, Gilberto Schwartsmann, Rafael Roesler, René Delgado, Gilberto L. Pardo‐Andreu	5
6	Recent Therapeutic Advances for Treating Medulloblastoma: Focus on New Molecular Targets 2010 ·CNS & Neurological Disorders - Drug Targets ·Andrew Schmidt, Algemir Lunardi Brunetto, Gilberto Schwartsmann, Rafael Roesler, Ana Lúcia Abujamra	16
7	Effects of a gastrin-releasing peptide receptor antagonist on d-amphetamine-induced oxidative stress in the rat brain 2010 ·Journal of Neural Transmission ·Samira S. Valvassori, Morgana Moretti, Márcia Kauer-Sant’Anna, Rafael Roesler, Fabrícia Petronilho, Gilberto Schwartsmann, Flávio Kapczinski, Felipe Dal‐Pizzol, João Quevedo	10
8	Phosphoinositide 3-kinase is required for bombesin-induced enhancement of fear memory consolidation in the hippocampus 2009 ·Peptides ·Rafael Roesler, Samira S. Valvassori, Adalberto A. Castro, Tatiana Luft, Gilberto Schwartsmann, João Quevedo	19
9	A study of the killer cell immunoglobulin‐like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris 2008 ·Tissue Antigens ·Mariana Jobim, (unknown), Luiz Fernando Job Jobim, (unknown), Tânia Ferreira Cestari, (unknown), (unknown), (unknown), (unknown), Timothy J. Wilson, (unknown), (unknown), Gilberto Schwartsmann	22
10	Stimulation of Proliferation of U138-MG Glioblastoma Cells by Gastrin-Releasing Peptide in Combination with Agents That Enhance cAMP Signaling 2008 ·Oncology ·Caroline Brunetto de Farias, (unknown), (unknown), Débora G. Flores, Luíse Meurer, Algemir Lunardi Brunetto, Gilberto Schwartsmann, Rafael Roesler	30
11	A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients 2008 ·Annals of Oncology ·Xavier Pivot, P. Koralewski, Jorge Hidalgo, Arlene Chan, Anthony Gonçalvès, Gilberto Schwartsmann, Sylvie Assadourian, Jean‐Pierre Lotz	148
12	Expressão da MMP-9 e do VEGF no câncer de mama: correlação com outros indicadores de prognóstico 2008 ·Revista Brasileira Ginecologia e Obstetrícia ·(unknown), Gilberto Schwartsmann, (unknown), (unknown), (unknown), (unknown)	9
13	Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy 2007 ·Annals of Oncology ·(unknown), Rafael Roesler, Gilberto Schwartsmann	193
14	Radioresistance is associated to increased Hsp70 content in human glioblastoma cell lines 2004 ·International Journal of Oncology ·Adriana Brondani da Rocha, Andréa Regner, Ivana Grivicich, (unknown), (unknown), (unknown), Caroline Brunetto de Farias, (unknown), (unknown), (unknown), Gilberto Schwartsmann	53
15	Marine-derived anticancer agents in clinical trials 2003 ·Expert Opinion on Investigational Drugs ·Gilberto Schwartsmann, Adriana Brondani da Rocha, Jane Mattei, (unknown)	65
16	Sentinel lymph node identification and sampling in women with early breast cancer using 99mTc labelled dextran 500 and patent blue V dye 2001 ·Nuclear Medicine Communications ·(unknown), (unknown), (unknown), Sandra Cristina Pereira Costa Fuchs, (unknown), (unknown), (unknown), Jorge Villanova Biazús, José Antônio Crespo Cavalheiro, Gilberto Schwartsmann	12
17	Preclinical antitumour activity and animal toxicology studies of rhizoxin, a novel tubulin-interacting agent 1992 ·Annals of Oncology ·Hans R. Hendriks, Jacqueline Plowman, Dan Berger, Kenneth D. Paull, H.H. Fiebig, Øystein Fodstad, (unknown), R.E.C. Henrar, Herbert M. Pinedo, Gilberto Schwartsmann	25
18	In vivo inhibition of the pyrimidine de novo enzyme dihydroorotic acid dehydrogenase by brequinar sodium (DUP-785; NSC 368390) in mice and patients. 1990 ·PubMed ·Godefridus J. Peters, Gilberto Schwartsmann, Jorge Nadal, E. Laurensse, C.J. van Groeningen, W J van der Vijgh, H. M. Pinedo	74
19	A progress report of a phase I study of interferon-gamma and interleukin-2 and some comments on the mechanism of the toxicity due to interleukin-2 1989 ·Cancer Treatment Reviews ·John Wagstaff, Jan B. Vermorken, Gilberto Schwartsmann, R.J. Scheper, C.E. Hack, (unknown), A J Eerenberg-Belmer, Herbert M. Pinedo	7
20	Clinical trials in advanced breast cancer 1987 ·European Journal of Cancer and Clinical Oncology ·Gilberto Schwartsmann, Herbert M. Pinedo	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact